Improved detection reveals active &#946;-papillomavirus infection in skin lesions from kidney transplant recipients. by Borgogna C et al.
Improved detection reveals active
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The aim of this study was to determine whether detection of b-HPV gene products, as defined in
epidermodysplasia verruciformis skin cancer, could also be observed in lesions from kidney transplant
recipients alongside the viral DNA. A total of 111 samples, corresponding to 79 skin lesions abscised from 17
kidney transplant recipients, have been analyzed. The initial PCR analysis demonstrated that b-HPV-DNA was
highly present in our tumor series (85%). Using a combination of antibodies raised against the E4 and L1
proteins of the b-genotypes, we were able to visualize productive infection in 4 out of 19 actinic keratoses, and
in the pathological borders of 1 out of 14 squamous cell carcinomas and 1 out of 31 basal cell carcinomas.
Increased expression of the cellular proliferation marker minichromosome maintenance protein 7 (MCM7), that
extended into the upper epithelial layers, was a common feature of all the E4-positive areas, indicating that cells
were driven into the cell cycle in areas of productive viral infections. Although the present study does not
directly demonstrate a causal role of these viruses, the detection of E4 and L1 positivity in actinic keratosis and
the adjacent pathological epithelium of skin cancer, clearly shows that b-HPV are actively replicating in the
intraepidermal precursor lesions of kidney transplant recipients and can therefore cooperate with other
carcinogenic agents, such as UVB, favoring skin cancer promotion.
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Solid organ transplantation is a treatment offered to
an increasing number of patients with end-stage
organ diseases. Although lifesaving, organ trans-
plantation is associated with an overall three- to
fivefold increased risk of malignancies.1–4 Most of
these cancers are caused by reactivated viruses
whose oncogenic potential is suppressed by
immunological reactions in healthy individuals,
like Epstein–Barr virus-associated B-cell lympho-
mas, Kaposi’s sarcoma, caused by the reactivation of
human herpesvirus type 8, and Merkel cell carcino-
ma of the skin, associated with Merkel cell poly-
omavirus.5–9
Of the cancers presenting in organ transplant
recipients that have no established infectious etiol-
ogy, skin cancer is the most frequent form (95%),
including squamous and basal cell carcinomas.10–13
The incidence of skin cancer, the most common
cancer in fair-skinned populations, is at least 50-fold
higher in organ transplant recipients.14–16 Large
numbers of skin tumors (often more than 10) tend
to develop over time in these at-risk subjects, thus
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presenting an enormous challenge for the patients
and those responsible for their care.17,18
Nearly all adults are persistently infected in the
skin with many viruses belonging to the human
papillomavirus (HPV) family.19,20 Although they
appear not to cause overt clinical symptoms in a
great majority of infected individuals, they can cause
cancer, either in skin or in genital sites, particularly in
subjects with impaired immune function.21–25 To date,
more than 150 HPV types have been completely
sequenced and classified into five genera (and a series
of intragenus species, indicated by Arabic numbers)
based on DNA sequence analysis.26,27 Of these,
Alphapapillomaviruses (a-HPVs) are associated
with genital cancer (eg, HPV16 and 18) and some
genotypes with common skin warts.28 Skin-tropic
Betapapillomaviruses (b-HPVs) (eg, HPV5 and 8)
are evolutionarily distinct from the genus Alpha
and appear to cause widespread unapparent or
asymptomatic infections in the general population,
but they have been associated with skin cancer in
the immunocompromised host.29
The relationship between b-HPV infection and
skin cancer has been clearly defined in patients
suffering from the rare inherited disease epidermo-
dysplasia verruciformis, an autosomal recessive
disease characterized by a predisposition to infec-
tion by specific types of b-HPV.30–32 In these
patients, HPV5 and 8 replicate very efficiently and
reveal their full transforming potential, inducing
multiple cutaneous neoplasia.33,34
Emerging evidence also supports the role of b-HPV
in skin cancer development in immunosuppressed
individuals. Seroepidemiological studies have asso-
ciated skin cancer in organ transplant recipients
with the presence of anti-b-HPV antibodies, and
PCR-based studies have identified b-HPV DNA in
over 80% of skin tumors from these patients.22,35–43
Despite these findings, a causal role of these viruses
has been difficult to verify because of their ubiqui-
tous prevalence in the general population and their
absence in some cancers.25,44 The major weakness of
the available studies is that the proposed association
is mostly based on the presence of viral DNA in
tumor tissues or positive antibody responses. Very
few studies have addressed whether the b-HPV
detected in these cases are actually localized
within the malignant cells or whether they are
transcriptionally active, the confirmation of which
would greatly strengthen the evidence for a
carcinogenic role of these pathogens.
In a recent study, we examined the b-HPV life
cycle in skin tumors obtained from epidermo-
dysplasia verruciformis patients and found that,
similar to what has been seen with other PV types,
the onset of vegetative viral genome amplification
coincides closely with the cytoplasmic expression
of the viral protein E4 during productive infection.33
This pattern was observed in all areas of the tumors
where there was still some morphological differen-
tiation of the epithelium. In addition, we have also
demonstrated, using fluorescent in situ hybridi-
zation (FISH), that the abundance of b-HPV seen in
some lesions was a direct result of genome amplifi-
cation within the carcinoma tissue.34 Overall, our
results indicated that E4 staining could be exploited
as a marker of viral expression during b-HPV-
associated skin cancer progression as reported in
the HPV8 transgenic mouse model and in cervical
disease for the a-genotypes.33,45–47
To extend the data obtained so far in epidermo-
dysplasia verruciformis patients to other groups of
patients at high risk of developing skin cancer, here
we studied a series of skin lesions from kidney
transplant recipients attending our University Hos-
pital by systematically analyzing for the presence of
b-HPV infection both at the DNA (PCR) and protein
level. Using a combination of antibodies raised
against the E4 and L1 proteins of the b-genotypes,
we were able to visualize the completion of viral life
cycle in some precancerous lesions such as actinic
keratosis or at the periphery of more advanced
disease. These data demonstrate that b-HPV tran-
scription occurs at the site of skin transformation in
the organ transplant recipient setting and also points
to its possible involvement in the process of skin
carcinogenesis.
Materials and methods
Sample Collection
Tissue sections were obtained from 111 formalin-
fixed and paraffin-embedded blocks, previously
collected from 79 skin lesions and stored in the
University Hospital medical material archives. For
some lesions, only a single block was available,
denominated ‘whole lesion’ (WL), whereas for the
others, two blocks existed, corresponding to the core
(C) and edges (E) of the lesion. All lesions were
excised from 17 kidney transplant recipients, while
one among them had heart transplant twice
(16 male and 1 female), receiving transplants between
1998 and 2009. Data on skin lesion development
and characteristics were retrieved from pathology
archives and clinical records. The mean length of
patient follow-up following kidney transplantation
was 15 years and 4 months±7 years and 8 months.
A single formalin-fixed and paraffin-embedded block
from a wart-like lesion of a patient with epidermo-
dysplasia verruciformis was also analyzed in the
present study as positive control.
Written informed consent was obtained by all
subjects according to the Declaration of Helsinki and
approval was obtained from the local ethic committee.
b-HPV DNA Detection and Genotyping with the
PM-PCR Reverse Hybridization Assay
Two consecutive 10-mm-thick sections were retrieved
from formalin-fixed and paraffin-embedded samples
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and used to extract DNA by means of the QIAamp
Tissue Kit (Qiagen srl, Milan, Italy) according to
the manufacturer’s instructions. To prevent cross-
contamination, the microtome was thoroughly
cleaned following the sectioning of each block and
a new blade installed for the next. b-HPV detection
and genotyping was carried out using the PM-PCR
reverse hybridization assay (Skin b-HPV pro-
totype research assay; Diassay BV, Rijswijk, The
Netherlands), as described previously.48 The method
was designed to identify the 25 established b-HPV
types (ie, HPV genotypes 5, 8, 9, 12, 14, 15, 17, 19,
20, 21, 22, 23, 24, 25, 36, 37, 38, 47, 49, 75, 76, 80,
92, 93 and 96). The PM-PCR reverse hybridization
assay, which generated a biotinylated amplimer of
117bp from the E1 region, was carried out following
all the precautions indicated by the manufacturer to
avoid recurrence of cross-contamination. Briefly,
PM-PCR was performed in a final reaction volume
of 50 ml, containing 10 ml of the isolated DNA,
2.5mM MgCl2, 1 GeneAmp PCR buffer II,
0.2mM deoxynucleoside triphosphates, 1.5U
Amplitaq Gold DNA polymerase and 10 ml of the
PM primer mix. The PCR was performed by a 9-min
preheating step at 94 1C, followed by 35 cycles of
amplification comprising 30 s at 94 1C, 45 s at 52 1C
and 45 s at 72 1C. PCR was ended by a final
elongation step of 5min at 72 1C. As a positive PCR
control, a b-HPV plasmid clone was included.
Identification of the amplified HPV types was
performed by reverse hybridization analysis of the
amplimers on genotyping strips provided by the
manufacturer. In each strip a probe line contains
a mix of ‘universal’ HPV probes: in some cases,
these probes are positive without a probe for specific
b-HPV being positive, indicating the presence of an
unspecified b-HPV. These cases are indicated as
‘unspecified b-papillomavirus genotype.’
Antibodies and Generation of Anti-L1 Antibodies
To generate antibodies that can broadly identify the
L1 proteins of the b-genotypes, sequence alignments
were first carried out, and the highly conserved
region between amino acid 200 and 300 was chosen.
This region of the HPV5 full-length protein
(Ref. Seq.: NP_041372.1) was amplified by PCR from
an HPV5 genomic clone recently isolated from an
epidermodysplasia verruciformis patient. The primer
sequences used were: L1 forward, 50-CGCGGATCCC
GTCTGTATCCAAAACCCTTG-30; L1 reverse, 50-CCG
CTCGAGTTATCCTATAGTCTTTTGAGCTTG-30. The
forward primers included a BamHI site (underlined)
upstream of the ATG initiation codon, whereas the
reverse primers contained a XhoI sequence (under-
lined). Amplimers were cloned into the pGEX-4T-2
vector (GE Healthcare Europe GmbH, Milan, Italy),
and then expressed in the Escherichia coli
host BL21. GST-L1 fusion protein was dialyzed
overnight at 4 1C in 50mM Tris-HCl (pH 8.5),
0.5% b-mercaptoethanol and 3M urea, and then
redialyzed for 12h at 4 1C in 50mM Tris-HCl (pH
8.5) and protease inhibitors (Sigma). Antisera were
raised by injecting rabbits with the dialyzed GST-L1
fusion protein. Animals were bled 1 week after the
fourth immunization and serum immunoglobulins
obtained by precipitation with 45% saturated ammo-
nium sulfate. The precipitate was then resuspended in
phosphate-buffered saline (PBS) and purified on a
protein A affinity column (GE Healthcare) according
to the supplier’s specifications. Preimmune serumwas
collected before the initiation of the immunization
protocol and was used as a control in the immuno-
staining experiments.
The production of polyclonal antibodies to
HPV5E4, which crossreact with many genotypes
from species 1, including HPV8, 14, 20, 24, 25 and
36, has been described previously.33 Antibodies to
minichromosome maintenance protein 7 (MCM7)
were obtained from Neomarkers (Fremont, CA,
USA) (MS-862-p1).
Immunofluorescent Detection
Consecutive 5-mm-thick sections obtained from
formalin-fixed and paraffin-embedded tissues were
processed for immunofluorescent detection of anti-
gens coupled to DNA-FISH as described previously.49
For the other markers analyzed (E4, MCM7, L1),
antigen unmasking was performed by heating the
slides in a conventional decloaking chamber, where
they were placed for 10min at 121 1C in 10mM
citrate buffer at pH 6.0 (Vector Laboratories,
Burlingame, CA, USA). The immunofluorescent
protein–protein double detection (HPV5 E4-MCM7)
was carried out by incubating the slides overnight at
4 1C with the primary antibody anti-MCM7 (1:200)
diluted in 5% normal goat serum (NGS), followed by
amplification with TSA (Tyramide Signal Amplifi-
cation; Perkin-Elmer, Waltham MA, USA); then,
slides were incubated with the primary antibody
anti-HPV5 E4 (1:1000) for 3 h and subsequently with
the appropriate fluorescent secondary antibody. The
immunofluorescence (IF) for L1 detection was
carried out by incubating the slides overnight at
4 1C with the primary antibody anti-L1 (1:1000) diluted
in 5% NGS-PBS followed by incubation with the
appropriate fluorescent secondary antibody. Images
were acquired using a digital scanner (Pannoramic
MIDI; 3D Histech Kft., Budapest, Hungary). For the
assessment of histological features, the slides analyzed
by HPV5 E4-MCM7 were disassembled and stained
with hematoxylin and eosin (H&E).
Results
Patients and Skin Lesion Characteristics
The baseline characteristics of the study population
and the histological features of the cutaneous
lesions, alongside the relative number of lesions,
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the year in which they occurred following trans-
plantation and their location at sun-exposed or
unexposed sites are listed in Table 1. The median
time of skin lesion occurrence was 7±5 years after
transplantation. Patients are numbered in ascending
order based on the number of tumors developed.
Within 10 years from transplantation, 5 patients
developed more than 5 lesions (patients 13–17),
mostly in sun-exposed sites, confirming sun expo-
sure to be a major contributor to epithelial transfor-
mation. The skin lesions included: squamous cell
carcinoma (n¼ 14) and basal cell carcinoma (n¼ 31),
followed by precancerous lesions such as actinic
keratosis (n¼ 19), Bowen’s disease (n¼ 1) and
keratoacanthoma (n¼ 7), and benign lesions such
as seborrheic keratosis (n¼ 7). The proportion of
lesions affecting sun-exposed skin areas (head,
hands and forearms) was 59 out of 79 lesions (75%).
b-HPV-Type Determination
The results of b-HPV testing of the DNA extracted
from the 79 lesions are shown in Table 2. In 28 cases,
multiple biopsy blocks were available correspond-
ing to either the core or edges of the lesions. Out of
the 111 formalin-fixed and paraffin-embedded
blocks analyzed, 94 were HPV positive (85%) and
86 samples (77%) could be genotyped as containing
at least one of the 25 b-HPV genotypes available on
the reverse hybridization assay (Table 2).
The spectrum of b-genotypes identified for each
lesion from the 17 study patients is reported in
Supplementary Table 1. In cases of multiple biop-
sies, the genotypes found in the core and edges of
the tumors are combined. The most frequently
observed genotypes are HPV5 and 8 (both belonging
to species 1), which were found in 51 (65%) and 20
(25%) of the 79 lesions, respectively. HPV5 was
detected as a single infection in 18 out of the 79
lesions (23%) and HPV8 was detected as a single
infection in two lesions (3%). Multiple infections
with two genotypes were found in 13 lesions (16%),
while more than two genotypes were found in 28
lesions (35%). In the five patients exhibiting more
than 5 tumors, HPV5 alone or in multiple infections
was found in 38 (66%) of the 58 lesions present on
these 5 patients. Considering just the genotypes
belonging to species 1, including HPV5, 8, 12, 14,
19, 24, 25, 36 and 93, 61 tumors (77%) turned out to
be positive for at least one genotype. For the lesions
split into more formalin-fixed and paraffin-em-
bedded blocks (n¼ 36), at least one b1-genotype
was consistently found in 15 (42%) of them (data
not shown).
Visualization of Viral Protein Expression in Skin
Lesions
Previous studies from our group have demonstrated
that detection of the abundant viral E4 protein isT
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helpful for the visualization of active b-HPV infec-
tion in skin tumors from epidermodysplasia verru-
ciformis patients.33,34 Figure 1 shows representative
images of tissue sections from a benign wart-like
lesion from an epidermodysplasia verruciformis
patient displaying the unequivocal histological
features associated with the infection, including
acanthosis and the disorganization of the granular
layers defined by an abrupt variation in keratoyaline
granules. The E4-positive cells are enlarged and
display prominent blue-gray pallor with occasional
perinuclear halos. HPV8 DNA-FISH analysis con-
firmed that these cells are supporting viral genome
amplification as visualized by many positive
nuclei for overlapping cytoplasmic E4 staining.
Completion of the viral life cycle was also defined
by L1 staining performed using in-house polyclonal
antibodies raised against a common region of the
b-genus major capsid protein. As expected, L1-
positive nuclei were detected in the more superficial
layers of the E4-positive area.50 The cellular proli-
feration marker MCM7 was also strongly increased
in the lesion compared with the adjacent normal
epithelium being most apparent in the basal and
suprabasal layers, indicating that cells were
stimulated to enter the cell cycle.49,51
To investigate whether similar images of produc-
tive infection could be visualized in organ trans-
plant recipients skin lesions, tissue specimens from
the available formalin-fixed and paraffin-embedded
blocks were costained using IF analysis with anti-E4
and anti-L1 antibodies to detect viral antigen
expression, and with MCM7, a marker of cellular
proliferation.
Out of the 111 formalin-fixed and paraffin-
embedded blocks analyzed, E4-positive cells were
found in six blocks (for brevity, referred to as
IF-positive), originating from patients 5, 8, 16 and
17, and corresponding to four actinic keratosis
lesions, and the adjacent pathological area of one
squamous cell carcinoma and one basal cell carci-
noma. Patients 16 and 17 were transplanted in 1993
and 1999, respectively, and developed 14 skin
lesions each in their post-transplant period. The
other two patients received transplants in 2002 and
2005, respectively. Table 3 summarizes all the
lesions developed by the IF-positive patients and
reports the details of the genotyping results for each
formalin-fixed and paraffin-embedded block avail-
able, distinguishing the different parts of the lesions
(edges, core or WL). As expected from the spectrum
of the polyclonal anti-E4 antibody used, all the
IF-positive sections harbored genotypes belonging
to species 1.
Having established the epidermodysplasia verru-
ciformis staining pattern, we carefully went through
all the E4-positive areas identified in our tumor
series, looking for their major histological character-
istics and staining patterns, and the most represen-
tative images are presented. Figure 2 shows one of
the two E4-positive areas detected in the adjacent
pathological epithelium from a basal cell carcinoma
Figure 1 Distribution of the viral and cellular markers E4, L1, human papillomavirus 8 (HPV8) DNA and minichromosome maintenance
protein 7 (MCM7) in a wart-like lesion from an epidermodysplasia verruciformis patient (elbow). The top images show the scan of the
hematoxylin and eosin (H&E) histological staining (left) and immunofluorescence (IF) staining (MCM7 in red; E4 in green) (right) of the
same tissue section. The white dotted line indicates the basal layer. In the lower panel, the above-mentioned MCM7/E4 staining is
reproduced (left picture) and serial sections were double stained for the presence of viral genome amplification by HPV8 DNA-
fluorescent in situ hybridization (FISH) (red) and for E4 expression (green) (middle picture), and stained with antibodies to L1 (red) (right
picture). The region shown corresponds to the red square highlighted in the H&E image. The white arrows indicate nuclear L1 staining.
All sections were counterstained with 40,6-diamidino-2-phenylindole (DAPI) (blue) to visualize cell nuclei. Scale bars: 100mm.
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of the neck. The epithelium displays acanthosis and
both the E4 and L1 staining patterns show great
resemblance to those obtained from the epidermo-
dysplasia verruciformis patient shown in Figure 1.
Figure 3 summarizes the staining obtained from
patient 8, focusing on the positive area found in the
bowenoid actinic keratosis, located next to the
squamous cell carcinoma. This area shows clear signs
of b-HPV-related cytopathic effects, some cells display
pleomorphism and nuclear atypia and again both early
and late viral markers of b-HPV infection are present.
Three hypertrophic actinic keratosis, from the
same patient (patient 16), are reported in Figure
4a–c. Figure 4a shows a clearcut area of positivity
found in an epithelial crevice, where disruption of
the granular layer was clearly evident alongside
parakeratosis. In this case, it was also possible to
perform FISH with the single genotype found,
specifically HPV25; where FISH-positive nuclei
neatly overlapped with some E4-positive cells in
the cytoplasm, L1 positivity was confined to some
parakeratotic nuclei. The positive area reported in
Figure 4b was found in the pathological edge of an
actinic keratosis and shows the typical staining
pattern and cytopathic effects of productive b-HPV
infection. The actinic keratosis of Figure 4c shows
a positive area corresponding to a highly para-
keratotic epithelium that abruptly changed to
normal orthokeratosis on both sides. As expected
from the high grade of parakeratosis, many
L1-positive nuclei were found above the E4-positive
cells. Consistent with the staining seen in the
epidermodysplasia verruciformis lesion shown in
Figure 1, MCM7 expression was increased in all the
E4-positive areas, being present in the basal layer
and above (see especially Figure 4b). This staining
decreased following the onset of E4 expression,
although a region of overlap was well apparent
where E4-MCM7-double-positive cells were found.
A clear area of positivity was also found in the
adjacent pathological epithelium of a squamous cell
carcinoma, as reported in Figure 5. Here, the cyto-
pathic effect is remarkable and unequivocally simi-
lar to what is generally found in intraepidermal
precursor lesions from epidermodysplasia verruci-
formis and HIV patients.33,52 Many E4-positive cells
are present, as well as superficial L1-positive nuclei.
Unfortunately, although performed and present, we
Figure 2 Distribution of the viral and cellular markers E4, L1 and minichromosome maintenance protein 7 (MCM7) in a basal cell
carcinoma from a kidney transplant recipient (patient 5, neck). The top picture shows the scan of the tissue section using hematoxylin
and eosin (H&E) staining (scale bar: 1000mm). The blue circle shows the basal cell carcinoma and the red square indicates the area of
interest in the adjacent epithelium. The region shown in the lower panels (scale bars: 100 mm) corresponds to the red square highlighted
in the overall H&E image, magnified in the left-hand lower panel. In the middle picture, the same section was double stained using
antibodies to E4 (green) and MCM7 (red), and a serial section was stained with antibodies to L1 (red) (right picture). The white arrows
indicate nuclear L1 staining. All sections were counterstained with 40,6-diamidino-2-phenylindole (DAPI) (blue) to visualize cell nuclei.
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are not able to show FISH positivity with HPV24
because this slide turned out to be very fragile and
got severely damaged during processing.
In addition, the H&E staining of all the tissue
sections that were negative for viral markers were
carefully screened for the signs of any cytopathic
effects, while none observed.
Discussion
To our knowledge, this is the first study in which the
association between skin lesions and b-HPV infec-
tion has been assessed at both the DNA level by PCR
and at the protein level by IF analysis. The main aim
of this study was to determine whether detection
of b-HPV gene products, as defined in skin tumors
from epidermodysplasia verruciformis patients,
could also be observed in lesions from kidney trans-
plant recipients. We chose to compare the kidney
transplant recipients setting with epidermodyspla-
sia verruciformis because they share the following
two main features: (i) a status of chronic immuno-
suppression, which may favor persistence or reacti-
vation of latent skin-tropic viruses including b-HPV;
and (ii) the high risk of developing multiple skin
cancers.9,10,12 These commonalities are also valid for
patients affected by primary immunodeficiencies in
general.53 In addition, in this study the epidermo-
dysplasia verruciformis model served as an impor-
tant tool for optimizing the staining procedure with
anti-E4 and L1 antibodies, and was used as a
positive control when examining kidney transplant
recipient tissue sections. A polyclonal antibody
recognizing the E4 protein from species 1 was used
alongside a newly generated polyclonal antibody
raised against a highly conserved region of the L1
protein from the b genus. In addition, to increase the
chances of success, the biopsy blocks containing the
normal surrounding areas of the tumors were also
processed for the viral markers for a total of 111
formalin-fixed and paraffin-embedded correspond-
ing to 79 skin lesions abscised from 17 kidney
transplant recipients.
The initial PCR analysis demonstrated that
b-HPV-DNA was highly present in our specimens,
Figure 3 Distribution of the viral and cellular markers E4, L1 and minichromosome maintenance protein 7 (MCM7) in a bowenoid
actinic keratosis from a kidney transplant recipient (patient 8, neck). The top pictures (scale bars: 1000mm) show the scan of the tissue
sections using hematoxylin and eosin (H&E) staining; the right-hand panel shows an actinic keratosis with the area of interest boxed in
red and the left panel shows a nearby squamous cell carcinoma. The region shown in the lower panels corresponds to the red square
highlighted in the H&E image, magnified in the left-hand lower picture. The same section was double stained using antibodies to E4
(green) and MCM7 (red) (middle picture) and a serial section was stained with antibodies to L1 (red) (right picture). The white arrows
indicate nuclear L1 staining. All sections were counterstained with 40,6-diamidino-2-phenylindole (DAPI) (blue) to visualize cell nuclei.
Scale bars: 50mm.
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with 94 blocks (85%) resulting positive. Multiple
infections were observed in 41 lesions (52%), and
at least one genotype belonging to the b1 species
was found in 79 of the 111 blocks analyzed by
PCR (71%).
When we analyzed the same specimens by IF, six
blocks showed areas of positivity corresponding to
four actinic keratosis, and the adjacent pathological
epithelium of one basal cell carcinoma, and one
squamous cell carcinoma. The E4-positive areas
Figure 4 For caption see next page.
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were found in the context of the disorganized
epithelium in the actinic keratosis lesions, whereas
in the more advanced tumors, such as squamous cell
carcinoma and basal cell carcinoma, they were
always localized to the adjacent pathological epithe-
lium. In all the specimens, the viral E4 protein
displayed the expected cytoplasmic localization in
the middle-superficial layers of the epithelium
accompanied by an increase of the cellular proli-
feration marker MCM7 in the basal and suprabasal
layers. The disappearance of E4 positivity in the
adjacent normal epithelium constantly overlapped
with a reduction in MCM7 expression, which was
restricted to the basal layer. These findings support
the hypothesis that b-HPV replication drives the
cells above the basal layer to enter the cell cycle to
facilitate the amplification of its genome. Consistent
with this observation, FISH-positive nuclei for the
viral genome were found in some of the E4-positive
cells. As further proof that the viral life cycle was
Figure 4 Distribution of the viral and cellular markers E4, L1, human papillomavirus 25 (HPV25) DNA and minichromosome
maintenance protein 7 (MCM7) in three cases of hypertrophic actinic keratosis from a kidney transplant recipient (patient 16, a. hand; b.
face; c. hand). (a) The top picture (scale bar: 1000mm) shows the scan of the tissue section of the first actinic keratosis using hematoxylin
and eosin (H&E) staining. The region shown in the lower panels corresponds to the red square highlighted in the over H&E image,
reproduced in the lower left-hand picture. The same section was double stained using antibodies to E4 (green) and MCM (red) (second
picture); serial sections were double stained for the presence of viral genome amplification by HPV25 DNA-fluorescent in situ
hybridization (FISH) (red) and for E4 expression (green) (third picture), and also stained with antibodies to L1 (red) (fourth picture). The
white arrows indicate nuclear L1 staining. All sections were counterstained with 40,6-diamidino-2-phenylindole (DAPI) (blue) to
visualize cell nuclei. Scale bars: 50mm. (b) The top pictures (scale bars: 1000mm) show the scan of the tissue sections (using H&E
staining) of the second actinic keratosis (left picture) and its edge (right picture). The right-handed middle panel shows the histology
(H&E staining) of the area from the edge where viral markers were expressed (red square) and an overall picture of the
immunofluorescence (IF) staining (E4 in green; MCM7 in red) of the same tissue section (scale bars: 200 mm). The white dotted line
indicates the basal layer. In the lower panel, the above MCM7/E4 staining is reproduced (left picture) and serial sections were stained
with antibodies to L1 (red) (right picture). The white arrows indicate nuclear L1 staining. Scale bars: 100 mm. All sections were
counterstained with DAPI (blue) to visualize cell nuclei. (c) The top picture shows the scan of the tissue section of the third actinic
keratosis using H&E staining (scale bar: 1000mm). The black rectangle shows a magnification (scale bar: 400mm) of the positive
parakeratotic epithelium that abruptly changed to normal orthokeratosis on both sides. The region shown in the lower panels
corresponds to the red square highlighted in the H&E image, reproduced in the lower left-hand picture. The same section was double
stained using antibodies to E4 (green) and MCM7 (red) (middle picture) and a serial section was stained with antibodies to L1 (red) (right
picture). Scale bars: 50 mm. All sections were counterstained with DAPI (blue) to visualize cell nuclei.
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being completed, all the E4-positive areas showed
expression of the major coat protein (L1), which also
occurred in a subset of E4-positive cells in the upper
layers. This is fully consistent with what has been
seen with other PV types, where the onset of vegeta-
tive viral genome amplification coincides closely
with the expression of cytoplasmic E4 and nuclear
L1 in some very superficial cells during productive
infection.49–51 In one highly differentiated actinic
keratosis, the number of L1-positive nuclei was very
high and most of them were in the thick layers of
parakeratosis.
A common trait of cancers with a well-documen-
ted viral etiology is their high incidence in im-
munosuppressed individuals.5–9 As skin cancer is
the most prevalent tumor in the organ transplant
recipient setting, one would expect that viruses
may contribute to this well-documented increased
susceptibility and incidence. The discovery and
detection of b-HPV-DNA and its active infection in
epidermodysplasia verruciformis patients provided
an important new insight into the viral oncogenesis
of skin cancer that might be extendable to other
subsets of patients including other primary
immunodeficiencies and particularly long-lasting
iatrogenically immunosuppressed patients, such as
organ transplant recipients. Despite many efforts,
direct evidence of active b-HPV infection in tumors
from non-epidermodysplasia verruciformis patients
were still missing and the major criticism against a
direct involvement of these viruses in skin cancer in
the general population is that they do not seem to be
maintained in high-grade tumors, such as squamous
cell carcinoma. To date, the evidence suggesting a
causal role of b-HPV in skin cancer has been tainted
by: the finding that viral DNA is also found in
normal skin, that discovery of the viral genome copy
number is usually much less than one viral genome
per tumor cell and the fact that viral transcripts have
not been identified by high-throughput mRNA
sequencing.19,54–57 Alongside the fact that ubiqui-
tous b-HPV DNA carriage does not necessarily
indicate active infection, these issues have created
and so far maintained a state of uncertainty about
the causative role of b-HPVs in non-epidermo-
dysplasia verruciformis skin cancer. Although the
present study does not directly demonstrate a causal
role of these viruses, the detection of E4 and L1
positivity in (i) actinic keratosis, which are widely
regarded to be squamous cell carcinoma precursors
or in situ carcinoma, and (ii) the adjacent patho-
logical epithelium of one squamous cell carcinoma
Figure 5 Distribution of the viral and cellular markers E4, L1 and minichromosome maintenance protein 7 (MCM7) in the adjacent
epithelium of a squamous cell carcinoma from a kidney transplant recipient (patient 17, ear). The top pictures shows the scan of the
tissue sections (hematoxylin and eosin (H&E) staining) of the squamous cell carcinoma (left picture; scale bar: 500mm) and its edge (right
picture; scale bar: 1000mm). In the lower panel, the same sections were stained using antibodies to E4 (green) (middle picture) and serial
sections were stained with antibodies to L1 (red) (right picture). The region shown corresponds to the red square highlighted in the H&E
image. Scale bars: 50mm. All sections were counterstained with 40,6-diamidino-2-phenylindole (DAPI) (blue) to visualize cell nuclei. The
inset in the lower left picture shows the cytopathic effects typical of a productive b-human papillomavirus (HPV) infection (scale bar:
20mm).
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and one basal cell carcinoma, clearly shows that
b-HPV are actively replicating in the lesional skin of
organ transplant recipients and can therefore coope-
rate with other carcinogenic agents, such as UVB,
favoring skin cancer promotion and progression.
Our data are fully consistent with the model pro-
posed by Weissenborn et al55 in 2005, who demon-
strated that the highest b-HPV loads are present in
actinic keratosis, rather than in squamous cell carci-
noma, suggesting that their persistence may not be
necessary for the maintenance of the malignant
phenotype. Instead, they may act as a cofactor that
enhances the carcinogenic potential of UV damage,
as shown by Wallace et al,58 who also demonstrated
that b-HPV E6 expression can enhance the carcino-
genic potential of UV exposure by promoting p300
degradation.
If b-HPV infections has a role in skin cancer, then
they must do so transiently and very likely upon
reactivation or persistence in the immunocompro-
mised host. Our findings, showing active b-HPV
infection in precancerous lesions and in the vicinity
of malignant tumors, are fully compatible with a role
of these viruses in the early steps of skin carcino-
genesis in at least the immunosuppressed setting.
These data are consistent with the ‘hit-and-run’
mechanisms of carcinogenesis, with cutaneous HPV
being possibly important for tumor initiation and
progression but not necessary for tumor mainte-
nance.59,60 Consistent with a causal role in the
early stage of the disease, E4 positivity was clearly
visualized in an actinic keratosis that was localized
adjacent to a squamous cell carcinoma in the neck
region. In addition, increased MCM7 expression that
extended into the upper epithelial layers was a
common feature of all the E4-positive areas, indi-
cating that cells were driven into the cell cycle in
areas of productive viral infections.23,49,50 The
observed stimulation of basal cell proliferation
may contribute, in association with other transfor-
ming agents, such as UVB irradiation, to the
transformation process without necessarily being
maintained in the more advanced disease.
Assuming that viral replication is more active at
very early stages of carcinogenesis and perhaps
when lesions are not yet even clinically evident,
it is reasonable to propose that when lesions are
removed, especially in more advance stages, only
some residual areas are detectable that exhibit viral
replication. It is also worth mentioning that the
areas of positivity were usually found in lesions that
were originally split in more than one formalin-fixed
and paraffin-embedded blocks. This procedure is
currently applied when the surgical specimen is
quite big and the different areas of the lesion are
macroscopically evident as it is occurring when the
erythematosus area surrounding the tumor is also
surgically removed. This can also be defined as
field cancerization. These assumptions can explain
the low percentage of positivity found in this
kind of study and the need of more thorough inve-
stigation of the perilesional skin where the
likelihood of finding active bHPV infection
should be higher.
In summary, our work shows that careful detec-
tion of b-HPV gene products at the single-cell level
allows us to visualize their sites of replication,
especially in intraepidermal precursor lesions and
the marginal zones of more advanced disease.
However, these findings require further research to
improve our knowledge of b-HPV natural infection
and reactivation, which will help to understand
how it is influenced by the epithelial site, UVB
exposure and the immune system.
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